Skip to content
OpenCapital
Get started

Amylyx Pharmaceuticals, Inc. AMLX Q3 2025 earnings

Reported November 6, 2025 · Before market open

Revenue-
EPS-$0.37Beat by $0.06
EPS estimate-$0.43

Next report

Aug 6, 2026 (In 1 week)
EPS estimate-$0.36

Financials

Q3 2025

Income statement

See full
Revenue--100%
Gross profit--100%
Operating income-$36.0M+52.4%
Net income-$34.4M+52.7%
EPS (diluted)-$0.37+65.4%

Balance sheet

See full
Cash & equivalents$225.2M+213%
Total debt$5.9M+16.4%
Total equity$332.0M+69.2%
Total assets$362.7M+44.7%

Cash flow

See full
Operating cash flow-$30.4M+26.9%
CapEx$24.0K—
Free cash flow-$30.4M+26.9%

Valuation & ratios

Valuation

as of 09/30/25
See full
Market cap$1.45B+558%
Enterprise value$1.23B+701%

Returns & leverage

See full
Return on equity-56.5%-14.0pp
Debt / equity0×0.0×
Current ratio13.7×+9.2×

Versus estimates

Revenue

Q4 2024$665.0K

Diluted EPS

Q1 2026-$0.37Miss by $0.03Q4 2025-$0.30Beat by $0.01
Q3 2025-$0.37Beat by $0.06
Q2 2025-$0.46Miss by $0.02Q1 2025-$0.42Beat by $0.03Q4 2024-$0.55Miss by $0.06

Ask the moment Amylyx Pharmaceuticals, Inc. reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Amylyx Pharmaceuticals, Inc. report Q3 2025 earnings?
Amylyx Pharmaceuticals, Inc. (AMLX) reported Q3 2025 earnings on November 6, 2025 before market open.
What were Amylyx Pharmaceuticals, Inc.'s Q3 2025 revenue and EPS?
Amylyx Pharmaceuticals, Inc. reported revenue of - and eps of $-0.37 for Q3 2025.
Did Amylyx Pharmaceuticals, Inc. beat estimates in Q3 2025?
EPS beat the consensus estimate of $-0.43 by $0.06.
How did Amylyx Pharmaceuticals, Inc.'s Q3 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue declined 100.0% from $416.0K a year earlier and eps grew 30.2% from $-0.53.
Where can I find Amylyx Pharmaceuticals, Inc.'s Q3 2025 SEC filings?
You can read the 8-K earnings release (0001193125-25-268043) and the 10-Q periodic report (0001193125-25-268059) directly on SEC EDGAR. The filing index links above go to sec.gov.